LEXINGTON, Mass.--(BUSINESS WIRE)--EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, today announced that Sharon Shacham, Ph.D., vice president of drug development at EPIX, is scheduled to present at the Eighth Annual Structure-Based Drug Design Conference at the World Trade Center in Boston on Friday, June 27, 2008 at 11:00 a.m. (ET). Dr. Shacham’s presentation will take place during a session that focuses on Structure-Based Modeling of GPCRs and the presentation will feature EPIX’s unique approach to drug discovery including their proprietary PREDICT™ technology.
